THE "NEW" PROSTATE CANCER INFOLINKEntries RSS | Comments RSS Follow The "New" Prostate Cancer InfoLink news blog on TWITTER or FACEBOOK.
The "New" Prostate Cancer InfoLink has been developed to become a primary source of accurate, current, and topical information about prostate cancer for patients and their families.
This web site is a service of Prostate Cancer International.
Other PCI web sites
El Cáncer de Próstata Latinoamérica
Prostate Cancer Africa
Prostate Cancer Caribbean
Solidarité Prostate InfoLink
The "New" Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services.
News and information provided on this site should not be used for diagnosing or treating any health problem or disease.
The "New" Prostate Cancer InfoLink is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.
Perspective Confidentiality Disclosure Reliability Courtesy
Copyright © 2008-11 Prostate Cancer International, Inc.Funding for the DoD PCRP in FY 2012
Posted on June 16, 2011 by Sitemaster
iRate This
So here’s a quick status report on the potential funding for the US Department of Defense (DoD) Prostate Cancer Research Program (PCRP) for the fiscal year (FY) that begins on October 1, 2012 and runs through September 30, 2013.
As regular readers of this news blog may remember, funding for FY 2011 was renewed at the same level of $80 million as we had seen in the preceding few fiscal years. Congress has now initiated the process of looking at funding for the Department of Defense in FY 2012, and our current understanding is that there will be cuts to many of the Congressionally Directed Medical Research Program (CDMRP) initiatives, including the PCRP.
At this time, the House Appropriations Committee has proposed a 20 percent cut to the PCRP, which will mean a reduction in the total budget for PCRP from $80 million to $64 million for FY 2012. This is not good, but it could have been a lot worse. However, this is also just the first step in what may be a long process. We believe that the House of Representatives will vote on this bill some time next week. Hopefully, it will pass without any further fuss, but then we will have to wait and see what the Senate decides to do, and that could take a while.
For new readers, the PCRP is the largest single source of US government funding specifically dedicated to prostate cancer research. At its height, in FY 2001, a total of $100 million was dedicated to this initiative. Securing continuing funding for the PCRP is a critical priority for the Prostate Cancer Roundtable here in the USA. As a group, under the current economic circumstances, it is probably safe to say that the Roundtable members would be willing to live with a 20 percent budget cut of this type — even if we don’t like it! However, …
Subscribe to:
Post Comments (Atom)
As an Agent Orange prostate cancer survivor, I have served as consumer reviewer on five scientific panels which have resulted in cutting edge research which has improved diagnosis and treatment of this dread disease. It is painful to see PCRP appropriations cut over the last decade or so from $100 million down to 2012's proposed $64 million. I recommend that we all call our legislators to at least contact your legislators to force them to tell you where they stand on this important issue!
ReplyDelete